Literature DB >> 17382517

Identification of Rgl3 as a potential binding partner for Rap-family small G-proteins and profilin II.

Jiegou Xu1, Shuliang Shi, Naoya Matsumoto, Makoto Noda, Hitoshi Kitayama.   

Abstract

A cDNA encoding a RalGDS-related protein, Rgl3, was isolated by yeast two-hybrid screening using a small G-protein, Rap1, as a bait. Rgl3 mRNA is commonly detectable in several visceral organs (e.g. kidney, heart, liver, and lung) in the mouse and human. The Rgl3 protein mainly localizes in the cytoplasm when expressed in fibroblasts. Yeast two-hybrid assay indicated that Rgl3 could interact with Rap1, Rap2, H-Ras, N-Ras, and R-Ras but failed to interact efficiently with Ral and Rho. Interestingly, Rgl3 was found to affect cell morphology in two assay systems in culture. First, Rgl3 suppressed cell-spreading induced by Rap1, R-Ras, or C3G-CAAX (a membrane-targeted Rap/R-Ras activator) in HEK-293 cells. Second, Rgl3 enhanced the focus-formation induced by oncogenic H-Ras and N-Ras mutants in NIH3T3 cells. Moreover, we identified profilin II as a potential binding partner for Rgl3 by yeast two-hybrid screening. This interaction requires the characteristic proline cluster in the Rgl3 amino-terminal domain. Profilin II and Rgl3 co-operated in enhancing the N-Ras-induced focus-formation. These findings raise the possibility that Rgl3 mediates interaction between Ras/Rap-family proteins and profilin II, an important activator of actin polymerization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382517     DOI: 10.1016/j.cellsig.2007.02.004

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

1.  Ras-related GTPases Rap1 and RhoA collectively induce the phagocytosis of serum-opsonized zymosan particles in macrophages.

Authors:  Jae-Gyu Kim; Mi-Young Moon; Hee-Jun Kim; Yi Li; Dong-Keun Song; Jun-Sub Kim; Jae-Yong Lee; Jaebong Kim; Sung-Chan Kim; Jae-Bong Park
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

2.  The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery.

Authors:  Nicole F Neel; Timothy D Martin; Jeran K Stratford; Tanya P Zand; David J Reiner; Channing J Der
Journal:  Genes Cancer       Date:  2011-03

3.  The R-Ras/RIN2/Rab5 complex controls endothelial cell adhesion and morphogenesis via active integrin endocytosis and Rac signaling.

Authors:  Chiara Sandri; Francesca Caccavari; Donatella Valdembri; Chiara Camillo; Stefan Veltel; Martina Santambrogio; Letizia Lanzetti; Federico Bussolino; Johanna Ivaska; Guido Serini
Journal:  Cell Res       Date:  2012-07-24       Impact factor: 25.617

4.  EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation.

Authors:  M Huang; S Anand; E A Murphy; J S Desgrosellier; D G Stupack; S J Shattil; D D Schlaepfer; D A Cheresh
Journal:  Oncogene       Date:  2011-10-03       Impact factor: 9.867

5.  The QTL GNP1 Encodes GA20ox1, Which Increases Grain Number and Yield by Increasing Cytokinin Activity in Rice Panicle Meristems.

Authors:  Yuan Wu; Yun Wang; Xue-Fei Mi; Jun-Xiang Shan; Xin-Min Li; Jian-Long Xu; Hong-Xuan Lin
Journal:  PLoS Genet       Date:  2016-10-20       Impact factor: 5.917

6.  Effects of NRAS Mutations on Leukemogenesis and Targeting of Children With Acute Lymphoblastic Leukemia.

Authors:  Jiabi Qian; Zifeng Li; Kunlin Pei; Ziping Li; Chunjie Li; Muxia Yan; Maoxiang Qian; Yuanbin Song; Hui Zhang; Yingyi He
Journal:  Front Cell Dev Biol       Date:  2022-02-08

7.  RUFY, Rab and Rap Family Proteins Involved in a Regulation of Cell Polarity and Membrane Trafficking.

Authors:  Yasuko Kitagishi; Satoru Matsuda
Journal:  Int J Mol Sci       Date:  2013-03-21       Impact factor: 5.923

8.  Exome sequencing in pooled DNA samples to identify maternal pre-eclampsia risk variants.

Authors:  Tea Kaartokallio; Jingwen Wang; Seppo Heinonen; Eero Kajantie; Katja Kivinen; Anneli Pouta; Paul Gerdhem; Hong Jiao; Juha Kere; Hannele Laivuori
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.